氟环孢素作为表皮松解症的一线治疗药物。 - Suppr

Suppr

超能文献

FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.

作者信息

Morgado-sCarrasco D, Fustà-Novell X, Iranzo P

机构信息

Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España.

出版信息

Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):601-603. doi: 10.1016/j.ad.2018.01.014. Epub 2019 Apr 7.

DOI:10.1016/j.ad.2018.01.014

PMID:30971332

Abstract

摘要

相似文献

FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.

Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):601-603. doi: 10.1016/j.ad.2018.01.014. Epub 2019 Apr 7.

RF - Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Treatment Update.

Actas Dermosifiliogr. 2016 Apr;107(3):247-8. doi: 10.1016/j.ad.2015.05.003. Epub 2015 Jun 29.

Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.

Indian J Dermatol Venereol Leprol. 2017 May-Jun;83(3):312-316. doi: 10.4103/ijdvl.IJDVL_201_16.

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Br J Dermatol. 2010 Oct;163(4):847-53. doi: 10.1111/j.1365-2133.2010.09863.x.

Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors.

J Invest Dermatol. 2018 Sep;138(9):2068-2072. doi: 10.1016/j.jid.2018.03.1496. Epub 2018 Mar 17.

Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate.

Acta Derm Venereol. 2004;84(1):90-1. doi: 10.1080/00015550310005906.

Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.

J Am Acad Dermatol. 2017 Jan;76(1):106-113. doi: 10.1016/j.jaad.2016.07.048. Epub 2016 Oct 4.

Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Dermatol Ther. 2019 Jan;32(1):e12758. doi: 10.1111/dth.12758. Epub 2018 Oct 30.

Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.

J Am Acad Dermatol. 2021 Aug;85(2):512-513. doi: 10.1016/j.jaad.2018.09.063. Epub 2019 Jan 8.

Stevens-Johnson syndrome in childhood.

Arch Soc Esp Oftalmol. 2017 May;92(5):241-244. doi: 10.1016/j.oftal.2016.10.003. Epub 2016 Nov 26.

引用本文的文献

Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.

Cyclosporine in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Experience from a Tertiary Care Centre of South Rajasthan.

Indian Dermatol Online J. 2020 Sep 28;12(1):116-122. doi: 10.4103/idoj.IDOJ_326_20. eCollection 2021 Jan-Feb.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.

作者信息

Morgado-sCarrasco D, Fustà-Novell X, Iranzo P

机构信息

Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España.

出版信息

Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):601-603. doi: 10.1016/j.ad.2018.01.014. Epub 2019 Apr 7.

DOI:10.1016/j.ad.2018.01.014

PMID:30971332

Abstract

摘要

相似文献

FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis.

Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):601-603. doi: 10.1016/j.ad.2018.01.014. Epub 2019 Apr 7.

RF - Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Treatment Update.

Actas Dermosifiliogr. 2016 Apr;107(3):247-8. doi: 10.1016/j.ad.2015.05.003. Epub 2015 Jun 29.

Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.

Indian J Dermatol Venereol Leprol. 2017 May-Jun;83(3):312-316. doi: 10.4103/ijdvl.IJDVL_201_16.

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Br J Dermatol. 2010 Oct;163(4):847-53. doi: 10.1111/j.1365-2133.2010.09863.x.

Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors.

J Invest Dermatol. 2018 Sep;138(9):2068-2072. doi: 10.1016/j.jid.2018.03.1496. Epub 2018 Mar 17.

Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate.

Acta Derm Venereol. 2004;84(1):90-1. doi: 10.1080/00015550310005906.

Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.

J Am Acad Dermatol. 2017 Jan;76(1):106-113. doi: 10.1016/j.jaad.2016.07.048. Epub 2016 Oct 4.

Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Dermatol Ther. 2019 Jan;32(1):e12758. doi: 10.1111/dth.12758. Epub 2018 Oct 30.

Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.

J Am Acad Dermatol. 2021 Aug;85(2):512-513. doi: 10.1016/j.jaad.2018.09.063. Epub 2019 Jan 8.

Stevens-Johnson syndrome in childhood.

Arch Soc Esp Oftalmol. 2017 May;92(5):241-244. doi: 10.1016/j.oftal.2016.10.003. Epub 2016 Nov 26.

引用本文的文献

Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.

Cyclosporine in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Experience from a Tertiary Care Centre of South Rajasthan.

Indian Dermatol Online J. 2020 Sep 28;12(1):116-122. doi: 10.4103/idoj.IDOJ_326_20. eCollection 2021 Jan-Feb.